COMPANY PROFILE

Pillar Biosciences

Explore full profile

Pillar Biosciences is prized with its patent-pending targeted sequencing technology platform

Natick, United StatesFounded 2014Biotech & Life Sciences

Valuation $100–500M Latest valuation · 2026

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

At a glance

Status: Operational
Founded: 2014
Headquarters: Natick, United States
Employees: 70
Open positions: None listed
Dealroom signal: 81.6/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Personal Health, Testing, Biotechnology, Oncology, Genetics and genomics, Biotech and Pharma, Hard Tech, medical testing, DT and LS, science-based
Client focus: b2b
Links: Website LinkedIn X

Latest news

Press, funding announcements and product moves mentioning Pillar Biosciences.

See all news

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VCOther financing	May 2026	$14M	$173M	Undisclosed	↗
LATE VCOther financing	May 2025	$35M	$138M	Illumina · Soleus Capital	↗

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Pillar Biosciences website traffic

Latest recorded traffic for Pillar Biosciences is 2.1K monthly website visits, down 30% over the last three months. Pillar Biosciences's team grew 0% over the past year.

Latest monthly visits2.1K 3-month web change-30% 1-year team growth0%

Monthly website visitsOct 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
BIBillionToOneThe only genetic testing platform that accurately and efficiently detects and measures disease at the molecular level	Menlo Park, United States	Operational	839	$391M	$4.3B
MLMedGenome LabsA genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome	Foster City, United States	Operational
MUMultiplicom#Multiplicom is the leading Belgian biotech company that develops, manufactures and commercializes molecular diagnostic tests that enable personalized medicine	Antwerp, Belgium	Acquired
MAMapmygenomeA molecular diagnostics company	Hyderabad, India	Operational
FIFitgenesAustralian organization that delivers personalized, genome-based health and wellness programs	Brisbane, Australia	Operational
ANAnchorDxAnchorDx is a precision medicine firm	Guangzhou, China	Operational
GEGeneAdviserOur mission is to make genetic testing for rare diseases more accessible to clinicians around the world	Cambridge, United Kingdom	Operational
PEPertheraHope to advanced-stage cancer patients through advanced tumor analysis	McLean, United States	Operational